Notícias e Atividades da Repertoire Immune Medicines

Veja o organograma con seus 16 executivos principais

Biografias mais buscadas da Repertoire Immune Medicines

• Torben Nissen, Chief Executive Officer
• Doug Cole, Director
• JC Gutierrez-Ramos, Director

Criar um alerta
para seguir os movimentos de executivos da Repertoire Immune Medicines.

Repertoire Immune Medicines possui 2.350 concorrentes concorrentes Eurofins (Luxemburgo), Lonza (Suíça) e Johnson & Johnson Innovative Medicine DIA (Estados Unidos).

Popular M&A news in Biotecnologia

• Transcarent and Accolade have merged  (publicado em 9 de abril de 2025)..
• Kashiv BioSciences acaba de anunciar uma arrecadação de fundos de 150 milhões de dólares. (publicado em 7 de abril de 2025).
• Atsena Therapeutics acaba de anunciar uma arrecadação de fundos de 150 milhões de dólares. (publicado em 4 de abril de 2025).

Outros contatos sugeridos na indústria do Biotecnologia

• Kristina Burow - Director da Scholar Rock
• Steven Gillis - Chairman of the Board da VBI Vaccines
• Ali Behbahani - Non-Executive Director da Adaptimmune Therapeutics

Saiba mais sobre a indústria do Biotecnologia

Últimos comunicados de imprensa de Repertoire Immune Medicines

• Repertoire® Immune Medicines and Bristol Myers Squibb Announce Multi-Year Strategic Collaboration to Develop Tolerizing Vaccines for Autoimmune Diseases • Repertoire Immune Medicines
• Repertoire® Immune Medicines Presents New Data From Its DECODE™ Platform Identifying Highly Prevalent Immunotherapeutic Targets in HPV-Positive Cancers, Unlocking Pathways for Potential Therapeutics • Repertoire Immune Medicines
• Torben Straight Nissen Joins Repertoire® Immune Medicines as Chief Executive Officer • Repertoire Immune Medicines
• New Data From Repertoire® Immune Medicines Demonstrate Effectiveness of Its DECODE™ Platform to Characterize and Identify New Immunotherapeutic Targets in HPV Positive Cancer • Repertoire Immune Medicines
• Repertoire® Immune Medicines Enters New Research Collaboration to Discover The T Cell Response to Therapy in HPV-Associated Cancers • Repertoire Immune Medicines
• Repertoire® Immune Medicines Identifies Novel Immune Targets in Pathogenesis of Type 1 Diabetes • Repertoire Immune Medicines
• Preclinical Research Published in SCIENCE ADVANCES Demonstrates Repertoire Immune Medicines’ Cell-tethering Technology Delivers Potent Interleukin-12 Directly to Solid Tumors Potentially Improving Effectiveness of Cellular Immunotherapies • Repertoire Imm
• https://s3.us-east-1.amazonaws.com/repertoire-assets.investeddigital.com/downloads/Repertoire-SITC-PRESS-RELEASE_FINAL_6-Nov-2020.pdf
• https://assets.website-files.com/5ced5bd7efec584ab6889c10/5e8cdcf19cd40fc9a661a001_JDRF%20T1D%20Fund%20Repertoire%20Press%20Release_Final.pdf
• Press Releases
• View more press releases Close

Redes sociais sobre Repertoire Immune Medicines

• Repertoire Immune Medicines na Wikipedia, Google News e Yahoo Finance
• Repertoire Immune Medicines na LinkedIn, Twitter e YouTube